Arthroplasty Today (Feb 2022)

Treatment of Prosthetic Joint Infection due to Listeria Monocytogenes. A Comprehensive Literature Review and a Case of Total Hip Arthroplasty Infection

  • Vasileios Athanasiou, MD, PhD,
  • Leonidia Leonidou, MD, PhD,
  • Alexandra Lekkou, MD, PhD,
  • Panagiotis Antzoulas, MD,
  • Konstantina Solou, MD,
  • Georgios Diamantakis, MD,
  • John Gliatis, MD, PhD

Journal volume & issue
Vol. 13
pp. 48 – 54

Abstract

Read online

As reported in contemporary literature, prosthetic joint infection (PJI) caused by Listeria monocytogenes (LM) is a rare infection affecting mainly immunocompromised patients. It is considered a late complication occurring months or years after the arthroplasty that is treated with, or without, implant retention, in one-stage or two-stage surgical procedures, and long-term administration of antibiotics. We reviewed the published studies in the English language and present a case of a patient who underwent total hip arthroplasty (THA) and had been affected by this infection. Our patient was successfully treated with 3 months of antibiotics (ampicillin and TMP/SMX) and a two-stage surgical procedure. The success rates of conservative treatment and one-stage or two-stage procedures are dependent on appropriate patient selection and chronicity of the infection. Ιmmmunocompromised patients are susceptible to PJI caused by LM and should be advised that consumption of unpasteurized dairy products increases the risk of this atypical infection.

Keywords